Articles by Alessia Argentieri
Columbus Venture invests in €7.4m round for Algenex
Columbus deploys capital from Columbus Life Science Fund II, which targets early-stage biotech startups
Ardian backs smart city specialist Wintics
Company plans to use the fresh capital to scale up its technology and accelerate its expansion
Bridgepoint Development Capital IV hits £1.5bn hard-cap
Fund exceeds its £1bn target after around eight months on the road, Unquote understands
TCV leads €90m series-B for Mollie
Company intends to use the fresh capital to further boost its expansion and broaden its product offering
Oaktree Capital buys Stade Malherbe Caen
GP invests in the company alongside French entrepreneur Pierre-Antoine Capton, who is appointed as chair
Ambienta opens Paris office, hires two new partners
Gwenaelle Le Ho Daguzan is appointed as partner in France and Hans Haderer in Germany
Abac buys five petcare companies
GP acquires the companies via Abac Solutions, which closed on €320m in May 2016
FIEE holds €127.5m first close for second fund
Fund targets the energy efficiency, renewables, lighting, co-generation, pollution control and smart city sectors
Nexxus Iberia buys STM
GP invests in the company via Nexxus Iberia Private Equity Fund I, which closed on €170m in February 2020
GP Profile: ArchiMed
Following the close of its new €1bn fund, ArchiMed's Denis Ribon discusses the firm's fundraising experience and investment pipeline
Heal Capital leads series-A for CereGate
Existing investors High-Tech Gründerfonds (HTGF) and TruVenturo also take part in the round
Gradiente buys Arcansas
GP invests in the company via Gradiente II, which held a final close on its €135m hard-cap in 2019
Mandarin Capital buys Sidam
GP intends to create a platform for new acquisitions across the biomedical sector in Italy
Muzinich Pan-European Private Debt II holds €210m first close
Fund provides capital to lower-mid-market companies to fuel their growth and finance their expansion strategy
Abac Capital backs Iberfrasa
GP invests via Abac Solutions, which closed on €320m in 2016 and is almost fully deployed across nine companies
Claris Biotech I holds €30m first closing
Fund targets early-stage rounds across the biopharmaceutical industry, focusing on oncology, immunology and rare diseases
Summit Partners invests in CluePoints
Company plans to use the fresh capital to boost its growth and expand its international presence
Nexxus Iberia backs Mercurius Health
GP invests via Nexxus Iberia Private Equity Fund I, which held a final close on €170m in February 2020
Investindustrial buys machinery producer Della Toffola
GP acquires a stake of 73.5%, while Vittorio, Francesco and Luciano Della Toffola retain the remainder
Inflexion buys minority stake in Auxadi
Inflexion intends to boost Auxadi's growth via additional acquisitions and geographic expansion
Apax, Fortress, Three Hills to bid for Serie A - report
Bidders join other PE firms that have shown interest in Serie A, including CVC, Bain and Advent
Panakes to launch €120m second fund within months
VC expects to start raising capital by the end of the year and hold a first close in H1 2021
Aksìa backs machinery manufacturer Vomm
Third acquisition made by Aksìa Capital V, following its investments in Primo and Valpizza
Ardian's Unither buys Chinese pharma company NRB
With this acquisition, Unither plans to accelerate the development of its business in China